Congratulations to Alnylam on the appointment of Dr. Pushkal Garg as EVP, Chief Research & Development Officer.

At GSS, we don't just help companies make great hires, we help them make lasting ones. Congratulations to Dr. Pushkal Garg on his appointment as EVP, Chief Research & Development Officer at Alnylam Pharmaceuticals. Since we partnered with Alnylam to place Dr. Garg in 2014, he has played a pivotal role in shaping and expanding one of the most #innovative R&D organizations in #biotech.   His continued #leadership as Alnylam enters its next chapter—advancing RNAi therapeutics to all major tissues by 2030—is a powerful testament to the long-term impact of getting the right hire, right from the start. #biotech #executivesearch #RNAi #leadership #RandD #hiringwithimpact

June 18, 2025 · Business Wire

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

A combined R&D organization aims to accelerate Alnylam's pipeline, with a goal of delivering RNAi therapeutics to all major tissues by 2030.

Alnylam has named Pushkal Garg, M.D., Executive Vice President and Chief Research and Development Officer, leading an integrated R&D organization. Garg joined the company in 2014 to build its Development group.

Read the full release

Source: Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), via Business Wire.